XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California.
| Revenue (TTM) | $48.55M |
| Gross Profit (TTM) | $48.09M |
| EBITDA | $8.29M |
| Operating Margin | -3.90% |
| Return on Equity | 34.20% |
| Return on Assets | 1.28% |
| Revenue/Share (TTM) | $4.03 |
| Book Value | $7.07 |
| Price-to-Book | 6.55 |
| Price-to-Sales (TTM) | 15.22 |
| EV/Revenue | 101.61 |
| EV/EBITDA | 15.50 |
| Quarterly Earnings Growth (YoY) | 207.90% |
| Quarterly Revenue Growth (YoY) | -22.60% |
| Shares Outstanding | $17.68M |
| Float | 882,010 |
| % Insiders | 2.93% |
| % Institutions | 85.06% |
Volatility is currently contracting